🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study with ALTB-268 will determine the safety, tolerability, pharmacok...
Status
Active Not Recruiting
Location
Syneos Health Clinical Research Services, LLC
Start Date
2025-11-17
Trial ID
NCT07350577
Study Hypothesis: Preterm infants administered weekly Darbe during the neon...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-09-20
Trial ID
NCT03169881
Treatments Being Tested
The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Status
Terminated
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Start Date
2013-03-15
Trial ID
NCT01732211
Treatments Being Tested
To study the effects of Erigeron Injection on human serum VEGF, MMP-9 and E...
Status
Unknown
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01926834
Treatments Being Tested
This is a Phase II, randomized, double-blind, placebo-controlled multicente...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00962832
Treatments Being Tested
This study will evaluate Tangible Boost, a new contact lens care product wh...
Status
Completed
Location
University of Houston
Start Date
2017-02-24
Trial ID
NCT03073148
Treatments Being Tested
This study attempts to learn about the effectiveness of a modification to t...
Status
Withdrawn
Location
University of Mississippi Medical Center
Start Date
2015-06
Trial ID
NCT02506855
Treatments Being Tested
This is a parallel, Phase 2, 2-arm, double-blind, randomized, multicenter, ...
Status
Terminated
Location
Medical Dermatology Specialists Site Number : 8400002
Start Date
2023-11-01
Trial ID
NCT06118099
Treatments Being Tested
The purpose of this study is to evaluate the mucolytic activity of Tacholiq...
Status
Completed
Location
Medaimun GmbH
Start Date
2014-08
Trial ID
NCT02515799
Treatments Being Tested
Clinical efficacy and tolerability for allergen specific immunotherapy (AIT...
Status
Completed
Location
Karolinska University Hospital
Start Date
2023-02-01
Trial ID
NCT06085963
Treatments Being Tested